Vipera berus Bites in the Region of Southwest Poland—A Clinical Analysis of 26 Cases
- 1 June 2010
- journal article
- Published by SAGE Publications in Wilderness & Environmental Medicine
- Vol. 21 (2) , 114-119
Abstract
Objective: Vipera berus is the only naturally occurring venomous snake in Poland. Its venom is primarily vasculotoxic and evokes both local and systemic findings. The aim of the study was to review a series of clinical cases of V berus bites occurring in southwest Poland. Methods: The charts of 26 patients (age range, 16–66 years; mean, 42 years) hospitalized with V berus bites were retrospectively analyzed using a data collection tool. Demographic and clinical data were extracted. Results: The most common local findings of envenomation were edema of the bitten limb with associated extravasations observed in 24 (92.3%) patients, but in only 1 (3.8%) case did the edema spread to the trunk. In 22 (84.6%) cases edema disappeared within 2 weeks after the bite. Systemic disturbances observed in the patients were: shock (1 case), mild transient hypotension (1 case), prolonged hypotension (3 cases), bronchospasm and laryngeal edema (1 case), diarrhea (1 case), transient supraventricular arrhythmias (2 cases), neutrophilic hyperleukocytosis (2 cases), and thrombocytopenia below 50 000 cells/μL (5 cases). In 16 patients (61.5%) the envenomation was classified as moderate and this type was predominant. Six cases were classified as severe. No fatal case was reported. Treatment included the administration of specific antivenom in 14 cases (in all severe and half of moderate cases) and symptomatic treatment applied in all cases. Conclusions: Moderate envenomation prevailed among the patients analyzed in the study. Antivenom treatment is primarily necessary in cases of severe (grade 3) and in some cases of moderate (grade 2) envenomation, especially in patients with persistent or recurring hypotension.Keywords
This publication has 13 references indexed in Scilit:
- Treatment of bites by adders and exotic venomous snakesBMJ, 2005
- Are anaphylactic reactions to snake bites immunoglobulin E‐mediated?Clinical & Experimental Allergy, 2000
- Envenimations par vipères européennes. Étude multicentrique de tolérance du Viperfav™, nouvel antivenin par voie intraveineuseAnnales Françaises d'Anesthésie et de Réanimation, 1998
- First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenomingJournal of Internal Medicine, 1997
- Treatment of adder (Vipera berus berus) envenoming with an ovine affinity purified Fab antivenomToxicon, 1996
- Viper Bites in France: Clinical and Biological Evaluation; Kinetics of EnvenomationsHuman & Experimental Toxicology, 1994
- Adder (Vipera berus) bites: a case report and review of the management for emergency medical personnel.Emergency Medicine Journal, 1993
- Second-degree heart block associated with envenomation by Vipera berus.Emergency Medicine Journal, 1988
- A Study of 136 Cases of Adder Bite Treated in Swedish Hospitals during One YearActa Medica Scandinavica, 1981
- Adder bites in Britain.BMJ, 1976